Whole genome sequencing precision medicine strategyto shorten treatment for rifampicin-resistant tuberculosis (SMARTT) : a pragmatic, randomised, single-blind phase 4 trial
Source
The lancet respiratory medicine - ISSN 2213-2600-14:6 (2026) p. 521-532
Prevalence of nontuberculous mycobacteria isolates and pulmonary disease from respiratory tract samples in persons investigated for presumed tuberculosis from three West African countries, an analysis of three prospective cohort studies
Source
BMC infectious diseases - ISSN 1471-2334-26:1 (2026) p. 1-12
Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa
Source
ERJ Open Research - ISSN 2312-0541-12:2 (2026) p. 1-11
The upcoming challenge of non-tuberculous mycobacterial pulmonary disease and tuberculosis/nontuberculous mycobacteria co-infection in Ghana and Sub-Saharan Africa
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Biomedical Sciences, 2026,204 p.
Retrospective cohort analysis for identification of discordant rifampicin-resistant Xpert MTB/RIF assay results in South Kivu, Eastern Democratic Republic of the Congo, a high burden tuberculosis setting
Source
Clinical infectious diseases - ISSN 1058-4838-82:2 (2026) p. 274-281